The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Tech in AsiaAsia

Nvidia to buy stakes in French startups Doctolib, Genesis AI

October 14

Nvidia also reportedly bought stakes in French startups Entalpic and Pigment.

Chips & compute

Read at Tech in Asia ↗

One letter a week, starting soon.

Latest

Nvidia to buy stakes in French startups Doctolib, Genesis AI

Related

AsiaNvidia’s China AI-chip share falls to 34% as Huawei gains Tech in Asia

Toolsb11607 llama.cpp releases

ValleyScience Corporation implants its vision-restoring chip in its first Stargardt disease patient TechCrunch AI

ValleyCerebras CEO says we’re nearing a future where everyone has a personal AI assistant at home TechCrunch AI

ValleyCerebras CEO pushes back on AI doomsday warnings TechCrunch AI